Influence of the dissociation rate constant on the intra-tumor distribution of antibody-drug conjugate against tissue factor
Open Access
- 1 August 2018
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 284, 49-56
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Center Research and Development (23-A-45)
- Japan Society for the Promotion of Science
- Council for Science and Technology Policy
This publication has 26 references indexed in Scilit:
- Multiscale Modeling of Antibody-Drug Conjugates: Connecting Tissue and Cellular Distribution to Whole Animal Pharmacokinetics and Potential Implications for EfficacyThe AAPS Journal, 2016
- Antibody-drug conjugates—an emerging class of cancer treatmentBritish Journal of Cancer, 2016
- Influence of Affinity and Antigen Internalization on the Uptake and Penetration of Anti-HER2 Antibodies in Solid TumorsCancer Research, 2011
- Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive LymphomasNew England Journal of Medicine, 2010
- Affinity and Avidity in Antibody-Based Tumor TargetingCancer Biotherapy and Radiopharmaceuticals, 2009
- Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug ConjugateCancer Research, 2008
- Antibody tumor penetration: Transport opposed by systemic and antigen-mediated clearanceAdvanced Drug Delivery Reviews, 2008
- Effect of antigen turnover rate and expression level on antibody penetration into tumor spheroidsMolecular Cancer Therapeutics, 2008
- cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activityBlood, 2003
- Tissue-level transport mechanisms of intraperitoneally-administered monoclonal antibodiesJournal of Controlled Release, 1998